Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (vol 54, pg 2817, 2006)

Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (vol 54, pg 2817, 2006)

Bibliografske podrobnosti
Main Authors: Maini, R, Taylor, P, Szechinski, J, Pavelka, K, Broll, J, Balint, G, Emery, P, Raemen, F, Petersen, J, Smolen, J, Thomson, D, Kishimoto, T
Format: Journal article
Izdano: 2008
Opis
Izvleček:

Podobne knjige/članki